Ignite Creation Date:
2024-07-17 @ 10:56 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488131
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-28
Brief Title:
Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
A Comparative Study Between MTA Pulpotomy and Root Canal Treatment in Management of First Permanent Molars With Irreversible Pulpitis in Children A Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dental caries highly prevalent amongst children can cause pulpitis Coronal pulpotomy provides an easier cost-effective conservative and biologically-driven treatment option compared to endodontic treatment in mature permanent teeth with irreversible pulpitis
The aim of the current study is to evaluate postoperative pain clinical and radiographic outcomes of MTA pulpotomy compared to root canal treatment in childrens first permanent molars suffering from irreversible pulpitis
The aim of the current study is to evaluate postoperative pain clinical and radiographic outcomes of MTA pulpotomy compared to root canal treatment in childrens first permanent molars suffering from irreversible pulpitis
Detailed Description:
In this randomized controlled trial patients aged 10-14 years suffering from irreversible pulpitis in the first permanent molar with closed apex will be randomly divided into two groups The first group will receive complete coronal MTA pulpotomy while the second group will receive endodontic treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None